Coya Therapeutics (COYA) vs Genelux (GNLX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Coya Therapeutics (COYA) has outperformed Genelux (GNLX) over the past year, losing 23.2% versus a loss of 46.5%. Coya Therapeutics is the larger company by market cap ($117.1 million vs $113.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COYA | GNLX |
|---|---|---|
| Share price | $4.99 | $2.50 |
| Market cap | $117.05M | $113.11M |
| 1-day change | +1.63% | -0.79% |
| YTD return | -15.34% | -42.20% |
| 1-year return | -23.16% | -46.50% |
| EPS (TTM) | $-1.07 | $-0.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.75 | $8.54 |
| 52-week low | $3.71 | $2.29 |
| Distance from 52-week high | -35.61% | -70.71% |
| Average volume | 159.93K | 274.06K |
| Shares outstanding | 23.46M | 45.25M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- COYA has outperformed GNLX by 23.3 percentage points over the past year.
COYA vs GNLX FAQ
Which is bigger, Coya Therapeutics or Genelux?
Coya Therapeutics (COYA) is larger, with a market capitalization of $117.05M compared with $113.11M for Genelux (GNLX).
Which stock has performed better over the past year, COYA or GNLX?
COYA returned -23.16% over the past 12 months, compared with -46.50% for GNLX (price return, excluding dividends). Past performance does not predict future results.
Are Coya Therapeutics and Genelux in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.